Allen A. Fienberg, VP of Business Development at Intra-Cellular Therapies, Inc. (ITCI), sold 5,000 shares at $19.00 ($95K) on 2015-01-14, disclosed to the SEC on 2015-01-16.
Scheduled sale ($95k) by VP of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.